Linked Life Data

18657673

Source:http://linkedlifedata.com/resource/pubmed/id/18657673

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-7-28
pubmed:databankReference
pubmed:abstractText
Atrial fibrillation is the most common significant cardiac arrhythmia and substantially impacts the health status of patients. Enoxaparin has been shown to be a safe and effective alternative to unfractionated heparin for use with transesophageal echocardiography (TEE)-guided cardioversion, but the implications on health status remain unknown. The aim of the study was to compare the health status outcomes of patients who undergo TEE-guided cardioversion with enoxaparin or unfractionated heparin as anticoagulation bridging therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1097-6744
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
156
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
374.e1-6
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
pubmed:affiliation
University of Pennsylvania Division of General Internal Medicine, Philadelphia, PA, USA. eldaniel@mail.med.upenn.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study